DK3501535T3 - Profylaktisk eller terapeutisk fremgangsmåde til svinepidemi-diarrévirus, vaccine og vaccinekit - Google Patents
Profylaktisk eller terapeutisk fremgangsmåde til svinepidemi-diarrévirus, vaccine og vaccinekit Download PDFInfo
- Publication number
- DK3501535T3 DK3501535T3 DK17841334.0T DK17841334T DK3501535T3 DK 3501535 T3 DK3501535 T3 DK 3501535T3 DK 17841334 T DK17841334 T DK 17841334T DK 3501535 T3 DK3501535 T3 DK 3501535T3
- Authority
- DK
- Denmark
- Prior art keywords
- vaccine
- therapeutic approach
- diarrhea virus
- epidemic diarrhea
- kit
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title 2
- 206010012735 Diarrhoea Diseases 0.000 title 1
- 241000282898 Sus scrofa Species 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
- A61K39/225—Porcine transmissible gastroenteritis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016159797A JP6253210B1 (ja) | 2016-08-17 | 2016-08-17 | 豚流行性下痢の予防又は治療方法、ワクチン、及びワクチンキット |
| PCT/JP2017/026692 WO2018034106A1 (ja) | 2016-08-17 | 2017-07-24 | 豚流行性下痢の予防又は治療方法、ワクチン、及びワクチンキット |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK3501535T3 true DK3501535T3 (da) | 2024-01-02 |
| DK3501535T5 DK3501535T5 (da) | 2024-09-02 |
Family
ID=60860075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17841334.0T DK3501535T5 (da) | 2016-08-17 | 2017-07-24 | Profylaktisk eller terapeutisk fremgangsmåde til svinepidemi-diarrévirus, vaccine og vaccinekit |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11013797B2 (da) |
| EP (1) | EP3501535B1 (da) |
| JP (1) | JP6253210B1 (da) |
| KR (1) | KR102439665B1 (da) |
| BR (1) | BR112019003126A2 (da) |
| CA (1) | CA3033730A1 (da) |
| DK (1) | DK3501535T5 (da) |
| ES (1) | ES2965854T3 (da) |
| MX (1) | MX2019001910A (da) |
| PH (1) | PH12019500330A1 (da) |
| TW (1) | TWI770041B (da) |
| WO (1) | WO2018034106A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11413347B2 (en) | 2019-09-02 | 2022-08-16 | Reber Genetics Co., Ltd. | Vaccine composition and method of preventing porcine epidemic diarrhea virus infection in swine |
| CN111471658A (zh) * | 2020-04-16 | 2020-07-31 | 武汉科前生物股份有限公司 | 一种病毒纯化方法及经由该方法制备得到的二联灭活疫苗 |
| KR102484824B1 (ko) * | 2020-09-03 | 2023-01-05 | 주식회사 중앙백신연구소 | 동물용 미끼백신 및 이의 제조방법 |
| CN115074334B (zh) * | 2021-03-15 | 2024-01-19 | 夏津新希望六和农牧有限公司 | 猪流行性腹泻病毒株、扩增培养方法、及其制备的疫苗组合物、制备方法和应用 |
| CN113430177B (zh) * | 2021-08-16 | 2022-09-02 | 山东信得科技股份有限公司 | 猪流行性腹泻病毒株、灭活疫苗、抗体及抗体的制备方法 |
| CN116286679B (zh) * | 2023-05-09 | 2023-08-01 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 一株经分离得到的猪流行性腹泻病毒变异株及其应用 |
| CN116966290B (zh) * | 2023-07-17 | 2024-05-28 | 浙江洪晟生物科技股份有限公司 | 猪流行性腹泻灭活疫苗制备方法及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10218788A (ja) * | 1997-02-07 | 1998-08-18 | Natl Fedelation Of Agricult Coop Assoc | 免疫増強剤の製造法および免疫増強法 |
| MXPA02012501A (es) * | 2000-06-16 | 2003-06-06 | Sembiosys Genetics Inc | El uso de cuerpos grasos vegetales en sistemas de administracion de vacunas. |
| WO2004087204A2 (en) * | 2003-04-04 | 2004-10-14 | Pfizer Products Inc. | Microfluidized oil-in-water emulsions and vaccine compositions |
| KR100622399B1 (ko) * | 2004-01-14 | 2006-09-18 | 대한민국 | 불활화시킨 ｔｇｅｖ 및 ｐｅｄｖ을 함유하는 혼합불활화백신 및 그 제조방법 |
| KR101442493B1 (ko) * | 2014-02-21 | 2014-09-26 | 우진 비앤지 주식회사 | 돼지유행성설사병바이러스 약독화주 및 이를 포함하는 돼지유행성 설사병 백신 조성물 |
| EA201691993A1 (ru) | 2014-04-03 | 2017-02-28 | Бёрингер Ингельхайм Ветмедика, Инк. | Вакцина к вирусу эпидемической диареи свиней |
| RS62414B1 (sr) * | 2014-07-11 | 2021-10-29 | Zoetis Services Llc | Nove kompozicije vakcine za virus svinjske epidemijske dijareje |
| CN104667269B (zh) * | 2015-02-02 | 2018-01-09 | 广东海大畜牧兽医研究院有限公司 | 一种猪流行性腹泻病毒鼻腔免疫疫苗及其制备方法 |
| KR101743142B1 (ko) * | 2015-09-09 | 2017-06-02 | 강원대학교산학협력단 | 즉시 사용가능한 마이크로에멀젼 기반의 비강내 면역화용 면역보강제 조성물 |
| KR101654023B1 (ko) * | 2015-10-28 | 2016-09-06 | 우진 비앤지 주식회사 | 돼지유행성설사병바이러스 약독화주 및 불활화백신 조성물과 이를 이용한 경구 투여용 백신 조성물 |
-
2016
- 2016-08-17 JP JP2016159797A patent/JP6253210B1/ja active Active
-
2017
- 2017-07-24 CA CA3033730A patent/CA3033730A1/en active Pending
- 2017-07-24 EP EP17841334.0A patent/EP3501535B1/en active Active
- 2017-07-24 KR KR1020197006764A patent/KR102439665B1/ko active IP Right Grant
- 2017-07-24 BR BR112019003126A patent/BR112019003126A2/pt unknown
- 2017-07-24 MX MX2019001910A patent/MX2019001910A/es unknown
- 2017-07-24 ES ES17841334T patent/ES2965854T3/es active Active
- 2017-07-24 WO PCT/JP2017/026692 patent/WO2018034106A1/ja unknown
- 2017-07-24 DK DK17841334.0T patent/DK3501535T5/da active
- 2017-07-24 US US16/325,615 patent/US11013797B2/en active Active
- 2017-08-01 TW TW106125846A patent/TWI770041B/zh active
-
2019
- 2019-02-15 PH PH12019500330A patent/PH12019500330A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018027903A (ja) | 2018-02-22 |
| US20190209676A1 (en) | 2019-07-11 |
| ES2965854T3 (es) | 2024-04-17 |
| JP6253210B1 (ja) | 2017-12-27 |
| KR102439665B1 (ko) | 2022-09-02 |
| EP3501535A1 (en) | 2019-06-26 |
| WO2018034106A1 (ja) | 2018-02-22 |
| EP3501535B1 (en) | 2023-09-20 |
| TW201825114A (zh) | 2018-07-16 |
| EP3501535A4 (en) | 2020-05-06 |
| BR112019003126A2 (pt) | 2019-07-09 |
| MX2019001910A (es) | 2019-05-15 |
| CA3033730A1 (en) | 2018-02-22 |
| US11013797B2 (en) | 2021-05-25 |
| PH12019500330A1 (en) | 2019-11-11 |
| TWI770041B (zh) | 2022-07-11 |
| DK3501535T5 (da) | 2024-09-02 |
| KR20190039204A (ko) | 2019-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3501535T3 (da) | Profylaktisk eller terapeutisk fremgangsmåde til svinepidemi-diarrévirus, vaccine og vaccinekit | |
| ZA202101615B (en) | African swine fever virus vaccine | |
| MA46766A (fr) | Vaccin antigrippal | |
| DK3472183T3 (da) | Variant adeno-associerede virus og fremgangsmåder til anvendelse | |
| DK3584252T3 (da) | Human immundefektvirus-antigener, -vektorer, -sammensætninger og fremgangsmåder til anvendelse deraf | |
| DK3400291T3 (da) | Manipuleret virus | |
| DK3557998T3 (da) | Sammensætninger, kompositioner og anvendelsesmetoder | |
| MA47677A (fr) | Vaccins peptidiques | |
| DK3580561T3 (da) | Hla-baserede metoder, sammensætninger og anvendelse heraf | |
| DK3258939T3 (da) | Neuroaktive steroider, sammensætninger og anvendelser heraf | |
| AP2016009664A0 (en) | Attenuated african swine fever virus vaccine | |
| DK3705488T3 (da) | Neuroaktive steroider, sammensætninger og anvendelse heraf | |
| EP3247389A4 (en) | INFLUENZAVIRUSSCHUTZIMPFPLÄNE | |
| DK3137168T3 (da) | Substituerede 4-phenylpiperidiner, deres fremstilling og anvendelse | |
| DK3288825T3 (da) | Teleskopisk adgangsbro, enhed forsynet hermed og tilhørende fremgangsmåde | |
| DK3558391T3 (da) | Immunkonjugater med adam9 som mål og fremgangsmåder til anvendelse deraf | |
| IL275849B (en) | Influenza virus vaccines and their uses | |
| DK3490988T3 (da) | Ny forbindelse og fremgangsmåde | |
| DK3355933T3 (da) | Adeninkonjugatforbindelser og deres anvendelse som vaccineadjuvanser | |
| DK3250550T3 (da) | Sammensætninger og fremgangsmåder til virussensibilisering | |
| MA53543A (fr) | Vaccins peptidiques | |
| DK3274447T3 (da) | Rekombinant fåresygevirus jeryl lynn 2 baseret vaccine | |
| DK3234159T3 (da) | Rekombinant svinekoppervirus og vacciner | |
| DK3371324T3 (da) | Virusbiomarkører og anvendelser deraf | |
| DK3274478T3 (da) | Hcv-ns4a/modificerede ns3-polypeptider og anvendelser deraf |